Skip to content
Open access · OA via Europe PMC

DELTA: Strengthening human biological resilience with an N=1 digital health and dynamic biomarker protocol.

Wang P, Foo N, Su C, Leung NYT, Song SW, Seres G, Sapanel Y, Hooi L, Wong A, Ong YH, Rai P, Park H, Chew HSJ, Wang LYT, Lee JWJ

PloS one · 2026

Abstract

Societies are aging rapidly in parallel with the increasingly earlier onset of serious diseases in younger populations. These and other factors are creating a substantial disparity between healthspan(definition), the period of life where an individual is free from serious chronic disease or disability, and lifespan - expanding the morbidity span. Extending healthspan has thus become a major priority. To pursue an integrated strategy toward healthspan support, we launched DELTA, a prospective, open-label, interventional, and participatory N = 1 study (NCT06630637) conducted on a healthy individual (DELTA001, author D.H.). The study was conducted with methodological rigor to support repeatability, transparency, and balanced reporting. The core focus of the DELTA protocol was to assess and enhance human biological resilience. This was demonstrated through the subject's adaptive capacity, revealed through changes and trajectories in cardiometabolic and pleiotropic biomarker levels based upon systematically administered challenges (e.g., fasting). Specifically, the interventional DELTA protocol integrates time-restricted eating (TRE, fasting), strength and cardiovascular fitness regimens, a Mediterranean-inspired dietary protocol, and supplementation alongside an analytics and reporting framework comprised of artificial intelligence (AI), digital health, and wearables-based sleep performance monitoring, microbiome assessment, and longitudinal tracking of biomarker dynamics and performance outcomes. This study introduces new methods and metrics for assessing these biomarker dynamics, including the development of digital biomarkers that reflect dynamic human functional resilience. Findings from DELTA may actionably guide the design of larger participatory human trials to monitor biomarker resilience, design appropriate interventions for dynamic administration, and subsequently strengthen healthspan at a population level.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1371/journal.pone.0354234
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
P, W., N, F., C, S., NYT, L., SW, S., G, S., Y, S., L, H., A, W., YH, O., P, R., H, P., HSJ, C., LYT, W., JWJ, L., X, T., &amp; D., H. (2026). DELTA: Strengthening human biological resilience with an N=1 digital health and dynamic biomarker protocol. <em>PloS one</em>. https://doi.org/10.1371/journal.pone.0354234
Vancouver
P W, N F, C S, NYT L, SW S, G S, et al. DELTA: Strengthening human biological resilience with an N=1 digital health and dynamic biomarker protocol. PloS one. 2026. doi:10.1371/journal.pone.0354234.
BibTeX
@article{wang2026DELTAS, title = {DELTA: Strengthening human biological resilience with an N=1 digital health and dynamic biomarker protocol.}, author = {Wang P and Foo N and Su C and Leung NYT and Song SW and Seres G and Sapanel Y and Hooi L and Wong A and Ong YH and Rai P and Park H and Chew HSJ and Wang LYT and Lee JWJ and Tadeo X and Ho D.}, journal = {PloS one}, year = {2026}, doi = {10.1371/journal.pone.0354234}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings